FDA Officials Push for Sweeping Vaccine Reform Amid Reports Linking COVID-19 Vaccines to Child Deaths
FDA officials are demanding agency reform and stricter vaccine approval processes following reports linking COVID-19 vaccines to 10 child deaths and concerns over data reliability, despite existing safety assurances.

FDA official plans to change vaccine approval process, claiming that Covid-19 shots caused child deaths | Politics

Strict New Rules Ahead: FDA Ties Coronavirus Jabs to Pediatric Deaths

FDA Chief Medical Officer Demands ‘Introspection’ by Staff After Report Tracing 10 Children’s Deaths to COVID Vaccine

FDA to raise hurdles for vaccines, faulting COVID shots for 10 kids' deaths
Overview
FDA officials are calling for significant agency reform and stricter vaccine approval processes after reports linked COVID-19 vaccines to the deaths of 10 children, prompting internal scrutiny.
Dr. Prasad, a key official, tasked FDA staff to evaluate VAERS reports on vaccine side effects and issued an ultimatum regarding review integrity, despite facing undermining leaks.
The FDA's own analysis indicates a potential link between COVID-19 vaccines and some deaths, including among children, though it's not identified as the sole cause.
New regulations will require pneumonia vaccines to demonstrate disease reduction and stricter authorization for pregnant women's vaccines, with CBER planning broader approval enhancements.
Critics, including Prasad, highlight the FDA's lack of reliable data to assess if COVID-19 vaccines saved more healthy children than harmed, and its failure to enforce safety studies.
Analysis
Center-leaning sources frame this story by initially emphasizing concerns about vaccine risks and regulatory failures, particularly regarding COVID shots for children. They highlight claims of 10 vaccine-related deaths and internal FDA calls for "honest" labels, even while including expert rebuttals. This approach creates a narrative of increased scrutiny and potential problems, despite presenting counter-evidence.